Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan F

Open source

DOI: 10.1136/bjophthalmol-2019-314251
Published: 2020 Apr
Container: The British journal of ophthalmology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bjophthalmol-2019-314251,
  title = {Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.},
  author = {Gale RP and Pearce I and Eter N and Ghanchi F and Holz FG and Schmitz-Valckenberg S and Balaskas K and Burton BJL and Downes SM and Eleftheriadis H and George S and Gilmour D and Hamilton R and Lotery AJ and Patel N and Prakash P and Santiago C and Thomas S and Varma D and Walters G and Williams M and Wolf A and Zakri RH and Igwe F and Ayan F},
  year = {2020},
  journal = {The British journal of ophthalmology},
  doi = {10.1136/bjophthalmol-2019-314251},
  url = {https://doi.org/10.1136/bjophthalmol-2019-314251}
}

RIS

TY  - JOUR
TI  - Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.
AU  - Gale RP
AU  - Pearce I
AU  - Eter N
AU  - Ghanchi F
AU  - Holz FG
AU  - Schmitz-Valckenberg S
AU  - Balaskas K
AU  - Burton BJL
AU  - Downes SM
AU  - Eleftheriadis H
AU  - George S
AU  - Gilmour D
AU  - Hamilton R
AU  - Lotery AJ
AU  - Patel N
AU  - Prakash P
AU  - Santiago C
AU  - Thomas S
AU  - Varma D
AU  - Walters G
AU  - Williams M
AU  - Wolf A
AU  - Zakri RH
AU  - Igwe F
AU  - Ayan F
PY  - 2020
JO  - The British journal of ophthalmology
DO  - 10.1136/bjophthalmol-2019-314251
UR  - https://doi.org/10.1136/bjophthalmol-2019-314251
ER  -

APA

RP, G., I, P., N, E., F, G., FG, H., S, S., K, B., BJL, B., SM, D., H, E., S, G., D, G., R, H., AJ, L., N, P., P, P., C, S., S, T., D, V., G, W., M, W., A, W., RH, Z., F, I., & F, A. (2020). Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.. The British journal of ophthalmology. https://doi.org/10.1136/bjophthalmol-2019-314251

Source records

pubmed · retrieved 2026-09-26T18:24:25.180Z
europe-pmc · retrieved 2026-09-26T18:24:25.210Z